9 pending office actions • 7 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (11%) |
| §103 only | 2 (22%) |
| §112 only | 2 (22%) |
| Multi-statute (no §101) | 4 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, JAE W | 1 | 65.6% | +39.0% |
| NOBLE, MARCIA STEPHENS | 1 | 67.0% | +40.3% |
| GROOMS, TIFFANY NICOLE | 1 | 58.8% | +46.8% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 47.6% | +50.0% |
| YOUTCHOM PENDIE, EMMANUEL LED | 1 | 55.6% | +50.0% |
| HUDSON, AMY ROSE | 1 | 75.0% | +11.4% |
| DHAR, MATASHA | 1 | 43.8% | +47.5% |
| PERREIRA, MELISSA JEAN | 1 | 52.0% | +25.9% |
| VIVLEMORE, TRACY ANN | 1 | 73.0% | +6.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17217612 | Transcription Factor Trapping by RNA in Gene Regulatory Elements | VIVLEMORE, TRACY ANN | 28d |
| 18773428 | METHODS OF EDITING DNA METHYLATION | LEE, JAE W | — |
| 18386551 | CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO | GROOMS, TIFFANY NICOLE | — |
| 18038943 | MODULATING TRANSCRIPTIONAL CONDENSATES | BUCHANAN, BAILEY CHEYENNE | — |
| 17878774 | CDC20 VARIANTS RESISTANT TO ANTI-MITOTIC DRUGS AND RELATED METHODS AND COMPOSITIONS | YOUTCHOM PENDIE, EMMANUEL LED | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17869611 | METHODS FOR LABELING AND TARGETING CELLS | HUDSON, AMY ROSE | 124d overdue |
| 18773428 | METHODS OF EDITING DNA METHYLATION | LEE, JAE W | — |
| 18635153 | METHODS FOR REPROGRAMMING SOMATIC CELLS | NOBLE, MARCIA STEPHENS | — |
| 18386551 | CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO | GROOMS, TIFFANY NICOLE | — |
| 18038943 | MODULATING TRANSCRIPTIONAL CONDENSATES | BUCHANAN, BAILEY CHEYENNE | — |
| 17878774 | CDC20 VARIANTS RESISTANT TO ANTI-MITOTIC DRUGS AND RELATED METHODS AND COMPOSITIONS | YOUTCHOM PENDIE, EMMANUEL LED | — |
| 17588038 | IN VIVO GUIDE RNA LIBRARIES AND METHODS OF MAKING THE SAME | DHAR, MATASHA | — |
| 17611560 | METHODS OF CHARACTERIZING AND UTILIZING AGENT-CONDENSATE INTERACTIONS | PERREIRA, MELISSA JEAN | — |
| Art Unit | Apps |
|---|---|
| 1632 | 2 |
| 1637 | 1 |
| 1682 | 1 |
| 1647 | 1 |
| 1636 | 1 |
| 1618 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18773428 | METHODS OF EDITING DNA METHYLATION | LEE, JAE W | — | §103§112 | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18635153 | METHODS FOR REPROGRAMMING SOMATIC CELLS | NOBLE, MARCIA STEPHENS | 1632 | §112 | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18386551 | CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO | GROOMS, TIFFANY NICOLE | 1637 | §102§103§112 | Non-Final OA | — | Pending | Nov 02, 2023 |
| 18038943 | MODULATING TRANSCRIPTIONAL CONDENSATES | BUCHANAN, BAILEY CHEYENNE | 1682 | §102§103§112 | Non-Final OA | — | Pending | May 25, 2023 |
| 17878774 | CDC20 VARIANTS RESISTANT TO ANTI-MITOTIC DRUGS AND RELATED METHODS AND COMPOSITIONS | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | §102§103 | Non-Final OA | — | Pending | Aug 01, 2022 |
| 17869611 | METHODS FOR LABELING AND TARGETING CELLS | HUDSON, AMY ROSE | 1636 | §112 | Final Rejection | 124d overdue | Pending | Jul 20, 2022 |
| 17588038 | IN VIVO GUIDE RNA LIBRARIES AND METHODS OF MAKING THE SAME | DHAR, MATASHA | 1632 | §103 | Non-Final OA | — | Pending | Jan 28, 2022 |
| 17611560 | METHODS OF CHARACTERIZING AND UTILIZING AGENT-CONDENSATE INTERACTIONS | PERREIRA, MELISSA JEAN | 1618 | §103 | Non-Final OA | — | Pending | Nov 15, 2021 |
| 17217612 | Transcription Factor Trapping by RNA in Gene Regulatory Elements | VIVLEMORE, TRACY ANN | 1638 | §101§102§103§112 | Final Rejection | 28d | Pending | Mar 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial